ERBB2 forms a heterodimer with another ERBB family member to form a more stable and strong signaling function and is considered to be an important therapeutic target for cancer (Giroux, 2013; Milik et al., 2017; Khanjani et al., 2018). The gene discussed is EGFR; the disease is cancer.